SmithKline Beecham Animal Health, et al.; Withdrawal of Approval of NADA's

ローカル自動翻訳 · 情報源の原言語

概要

The Food and Drug Administration (FDA) is withdrawing approval of three new animal drug applications (NADA's) and those portions of a fourth NADA providing for the use of nitrofurazone solution drug products. This action is being taken at the written request of the sponsors. In a final rule published elsewhere in this issue of the Federal Register, FDA is amending the regulations by removing the entries which reflect approval of the NADA's.

情報源の原言語: Federal Register — Health and Human Services原文の発表を開く →

SmithKline Beecham Animal Health, et al.; Withdrawal of Approval of NADA's

Office of Management and Budget (OMB) に提出された情報収集活動; Food and Drug Administration (FDA) の提出書類の提出; Customer/Partner Customer Service Satisfaction Surveys に関するコメントの要求

CDCのデータ収集計画についての意見募集

Office of the National Coordinator for Health Information Technology; Health Information Technology Advisory Committee; エンタイントにそすにしたプログルにしたプログにプログを定义にしたプログに。